Safinamide tatoside A and has been shown to

and has been shown to improve mitochondrial function and to confer significant cellular protection in neurons under stress

13-pentamethyl-16-[(1E)-1-(2-methyl-1

PubMed PMID: 24179414

CN(CC1=CC=CC=C1N(CCO)S(=O)(=O)C1C=CC(=CC=1)OC)C/C=C/C1C=CC(Cl)=CC=1

Safinamide tatoside A and has been shown toSafinamide, also known as FCE 26743 and EMD 1195686, is a drug indicated for the treatment of Parkinson's disease with multiple methods of action. Potential additional uses might be restless legs syndrome (RLS) and epilepsy. Safinamide is a reversible and selective monoamine oxidase B inhibitor, reducing degradation of dopamine, and a glutamate release inhibitor. It also inhibits dopamine reuptake. Additionally, safinamide blocks sodium and calcium